Trinity Biotech | TRIB - Operating Expenses


Trinity Biotech reported $14.82M in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Bayer EUR 9.88B 452M Mar/2026
Bio-Rad Laboratories USD 6.85B 6.21B Mar/2026
EDAP TMS EUR 18.8M 3.01M Sep/2025
J&J USD 17.44B 1.53B Mar/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Siemens EUR 16.57B 2.29B Dec/2025
Surmodics USD 29.51M 274.86M Jun/2025
Thermo Fisher Scientific USD 9.09B 821M Mar/2026
Tosoh JPY 238.2B 6.41B Mar/2026
Trinity Biotech USD 14.82M 7.81M Sep/2025
Veracyte USD 119.99M 3.99M Mar/2026